Biologically active secondary metabolites from myxobacteria.
New chemical structures with proven biological activity still are badly needed for a host of applications and are intensively screened for. Suitable compounds may be used as such, or in the form of their derivatives or, equally important, may serve as lead compounds for designing synthetic analogs. One way to new compounds is the exploitation of new producer organisms. During the past 15 years the myxobacteria have been shown in our laboratories to be a rich source of novel secondary metabolites, many of the compounds showing interesting and sometimes unique mechanisms of action. About 50 basic structures and nearly 300 structural variants have been elucidated, and almost all of them turned out to be new compounds. Several myxobacterial substances may have a good chance of an application.
Reichenbach
H
H
Gesellschaft für Biotechnologische Forschung, Microbial Secondary Metabolites, Mascheroder Weg 1, D-3300 Braunschweig, Germany.
Höfle
G
G